CDC-RFA-IP22-2203: Tracking the burden, distribution, and impact of Post COVID-19 conditions in diverse populations for children, adolescents, and adults (Track PCC)
Closed
This grant is closed. A newer notice from the same program is forecast: Informing global polio eradication efforts through innovative modeling approaches (CDC-RFA-JG-27-0077). Status: Expected deadline February 12, 2027. It is in our archive of Centers for Disease Control - NCIRD notices from 2022.
Centers for Disease Control - NCIRD offered grants of up to $2.0 million (at least $900,000) to any type of organization. It expected to make about 5 awards worth $45.0 million in total. Applications closed on March 8, 2022.
From the official notice on Grants.gov, last changed January 27, 2022. Checked November 7, 2026.
- Award ceiling$2.0 million
- Award floor$900,000
- Total funding$45.0 million
- Expected awards5
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | January 5, 2022 |
|---|---|
| Deadline | March 8, 2022 |
| Archived by Grants.gov | April 7, 2022 |
Who can apply
This opportunity was open to any type of organization.
All 12 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
The award ceiling for this NOFO is $2,000,000 for Component A and $1,000,000 for Component B. CDC will consider any application requesting an award amount higher than the ceiling amount as non-responsive and it will recieve no further review. Additional requirements for review include: Application table of contents, Project Abstract, project narrative (including work plan), budget narrative, letters of support from any proposed partners, CVs/resumes, organization charts, and copy of indirect cost-rate agreement. Required documents must be submitted, if not submitted the application will be considered non-responsive and will recieve no further review.
Is this a realistic fit?
- Past Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects awards averaged $3.5 million; this notice allows up to $2.0 million per award.
- Most of the program's money (47% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
The purpose of this notice of funding opportunity (NOFO) is to track and investigate the burden and impact of post-COVID-19 conditions (PCC) in diverse populations within the United States through surveillance and long-term follow-up of cohorts with PCC in collaboration with state, academic, or health networks. Post-COVID conditions include a wide range of health consequences that occur more than four weeks after initial SARS-CoV-2 infection. Studies will also explore risk factors and mitigating factors as they relate to the development, resolution, and prevention of PCC. NOFO will include two components: Component A- up to four surveillance sites and Component B -one coordinating center site.
Who has won Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects grants before
From fiscal 2021 to 2025, Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects (93.185) awarded $857 million across 243 grant awards, an average of $3.5 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Unicef | New York | 2 | $133 million |
| National Foundation for the Centers for Disease Control & Prevention, Inc. | Georgia | 2 | $74.7 million |
| Community Catalyst Inc | Massachusetts | 1 | $39.4 million |
| Pan American Health Organization | District of Columbia | 3 | $21.9 million |
| Unidosus | District of Columbia | 1 | $18.6 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, CDC-RFA-JG-27-0077, which is forecast.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is CDC-RFA-IP22-2203 still open?
No. It closed on March 8, 2022. A newer notice is forecast: CDC-RFA-JG-27-0077, expected deadline February 12, 2027.
Who can apply for Tracking the burden, distribution, and impact of Post COVID-19 conditions in diverse populations for children, adolescents, and adults (Track PCC)?
Centers for Disease Control - NCIRD accepted applications from any type of organization. The notice adds further conditions, so read its eligibility section.
What is the deadline for Tracking the burden, distribution, and impact of Post COVID-19 conditions in diverse populations for children, adolescents, and adults (Track PCC)?
Closed March 8, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $2.0 million each. About $45.0 million in total across about 5 awards.
Who has won Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects grants before?
The largest recipients over five fiscal years were Unicef, National Foundation for the Centers for Disease Control & Prevention, Inc., Community Catalyst Inc. The program made 243 awards worth $857 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)